pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

6,366 catalysts · 6,366 phase readout · 2,310 8k filing · 389 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 19 catalysts2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: patent expiry×clear all
type
  • phase readout6,366
  • 8k filing2,310
  • earnings389
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT04737720: Intravenous ACP-501 for Familial LCAT Deficiency (rhLCAT)

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Familial LCAT Deficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT05127824: Autologous Dendritic Cell Vaccine in Kidney Cancer

Sponsor: Jodi Maranchie. Phase: PHASE2. Conditions: Carcinoma, Renal Cell

full page →ctgov ↗
›RECRUITINGphase readoutNCT05940324: Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

Sponsor: Stanford University. Phase: PHASE2. Conditions: Obsessive-Compulsive Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT07179224: EEG Changes After rTMS Stimulation

Sponsor: BTL Industries Ltd.. Phase: NA. Conditions: Brain Electrical Reactivity to BTL-699-2 Stimulation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07547423: Auricular Laser Acupuncture for Improving Sleep in Breast Cancer Patients

Sponsor: CHING-RONG HUANG. Phase: NA. Conditions: Breast Cancer Females, Insomnia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06940323: Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)

Sponsor: University of California, San Francisco. Phase: . Conditions: Multiple Sclerosis, Clinically Isolated Syndrome, NMOSD, Myasthenia Gravis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07371962: Sound Bite-- a Therapeutic Song-writing Program

Sponsor: City University of Hong Kong. Phase: NA. Conditions: Depression

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07412262: A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression

Sponsor: Guangdong Association of Clinical Trials. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03523546: Oncology Episode Payment Model in Hawaii

Sponsor: University of Pennsylvania. Phase: NA. Conditions: Breast Cancer, Colon Cancer, Lung Cancer

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07558746: Measuring AI Reliance Among Intern Doctors in Palestine

Sponsor: Al-Quds University. Phase: NA. Conditions: Radiology, Internship and Residency, AI (Artificial Intelligence)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07530003: HUMSCs Combined With Col I to Third-Degree Burn Wound

Sponsor: The First Affiliated Hospital of Xinxiang Medical College. Phase: PHASE1. Conditions: Burn Wounds, Third-Degree Burn Wounds

full page →ctgov ↗
›COMPLETEDphase readoutNCT07406503: MRI-tDCS Stress and Future Thinking Study

Sponsor: Universitair Ziekenhuis Brussel. Phase: NA. Conditions: Healthy Participants

full page →ctgov ↗
›RECRUITINGphase readoutNCT01212003: Training Protocol on the Natural History of Tuberculosis

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Mycobacterium Infections, Tuberculosis, Multidrug-Resistant, Latent Tuberculosis, Tuberculosis, Extensively Drug-Resistant Tuberculosis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05791227: Safety and Efficacy Study of AI Wall Thickness Measurement (EchoNet-LVH-RCT)

Sponsor: Cedars-Sinai Medical Center. Phase: NA. Conditions: Heart Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT05346627: Home Based Personalized Training and Video Consultation in Mitochondrial Myopathies: Study of Efficacy and Tolerance.

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: NA. Conditions: Mitochondrial Myopathies

full page →ctgov ↗
›RECRUITINGphase readoutNCT05721261: Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation

Sponsor: Epineuron Technologies Inc.. Phase: NA. Conditions: Nerve Injury

full page →ctgov ↗
›COMPLETEDphase readoutNCT06766942: Effects of the Sherborne Developmental Movement Program on Motor Performance in Children With Autism Spectrum Disorders

Sponsor: Elif Dilan ATILGAN. Phase: NA. Conditions: Autism Spectrum Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06652542: Asthma Exacerbations & Respiratory Management International Survey

Sponsor: Assiut University. Phase: . Conditions: Acute Asthma Exacerbations

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03432286: A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Episodic Migraine

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07622186: A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)

Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07252986: Clinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by Artificial Intelligence

Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine. Phase: . Conditions: Breast, Breast Cancer, Pathology

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07655570: Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Cutaneous Angiosarcoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06323070: Effects of Watermelon or Low-fat Cookie Consumption on Wellness

Sponsor: San Diego State University. Phase: NA. Conditions: Overweight and Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07371273: Comparative Study on the Short- and Long-term Efficacy of Q-ISR, Traditional Sub-ISR, and t-ISR

Sponsor: Fudan University. Phase: PHASE2. Conditions: Colorectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06562569: Non-invasive VNS for Parkinson's Gait

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Parkinson's Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT04886869: Caffeine and the Autonomic Nervous System

Sponsor: LMU Klinikum. Phase: NA. Conditions: Autonomic Nervous System Imbalance

full page →ctgov ↗
›RECRUITINGphase readoutNCT01102569: Pancreatic Cancer Genetics

Sponsor: Columbia University. Phase: . Conditions: Pancreatic Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07230769: Bougie Diameter on Outcomes in Laparoscopic Sleeve Gastrectomy

Sponsor: General Committee of Teaching Hospitals and Institutes, Egypt. Phase: NA. Conditions: Bariatric Sleeve Gastrectomy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07662083: Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C

Sponsor: West Virginia University. Phase: NA. Conditions: Irritable Bowel Syndrome (IBS-C)

full page →ctgov ↗
›RECRUITINGphase readoutNCT04937283: Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China. Phase: NA. Conditions: Lung Adenocarcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04467983: Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

Sponsor: Hospital for Special Surgery, New York. Phase: PHASE4. Conditions: Osteoporosis, Postmenopausal

full page →ctgov ↗
›RECRUITINGphase readoutNCT07655583: OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy

Sponsor: M.D. Anderson Cancer Center. Phase: . Conditions: Brain Metastasis, Stereotactic Radiosurgery, Resection, Systemic Therapy

full page →ctgov ↗
›COMPLETEDphase readoutNCT01547741: Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Sponsor: NSABP Foundation Inc. Phase: PHASE3. Conditions: Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07670754: ORASIS in Breast Reconstruction

Sponsor: Duke University. Phase: NA. Conditions: DIEP Flap, Breast Reconstruction, Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07279454: The EAT-FIBRE Study.

Sponsor: King's College London. Phase: NA. Conditions: Microbiome Related Mechanisms Linked to Early Onset Colorectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07384754: Foot Strengthening to Improve Balance and Gait in Older Adults

Sponsor: Indiana University. Phase: NA. Conditions: Minimalist Footwear, Traditional Foot Exercise Program, Foot Strengthening Device (ToePro), Control Condition

full page →ctgov ↗
›COMPLETEDphase readoutNCT02476305: Evaluation of the Cryodestruction of Non Abdominopelvic Desmoid Tumors in Patients Progressing Despite Medical Treatment

Sponsor: University Hospital, Strasbourg, France. Phase: NA. Conditions: Desmoid Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07715305: A Clinical Trial to Evaluate the Bioequivalence of AD-116A Compared to AD-1161 in Healthy Adult Male Volunteers

Sponsor: Addpharma Inc.. Phase: PHASE1. Conditions: Benign Prostatic Hyperplasia

full page →ctgov ↗
›COMPLETEDphase readoutNCT05628805: Theta Burst Stimulation to Improve Inhibitory Motor Physiology in Tourette Syndrome

Sponsor: Children's Hospital Medical Center, Cincinnati. Phase: NA. Conditions: Tourette Syndrome, Tourette Syndrome in Children, Tourette Syndrome in Adolescence, Tourette Syndrome, Modifier of

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07400094: Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC

Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia. Phase: PHASE2. Conditions: Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms, Oral Cavity Neoplasm

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07630194: Occupation-Based Cognitive Stimulation With and Without Motivational Feedback in Parkinson's Disease

Sponsor: University of Nevada, Las Vegas. Phase: NA. Conditions: Parkinsons Disease With Mild to Moderate Memory and/or Thinking Problems

full page →ctgov ↗
›RECRUITINGphase readoutNCT06361394: The Impacts of Mindfulness on Psychological Wellbeing Among Nursing Students

Sponsor: Chang Gung University of Science and Technology. Phase: NA. Conditions: Psychological Well-being, Mindfulness, Problematic Internet Use

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05696366: Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes

Sponsor: University of California, San Diego. Phase: PHASE1. Conditions: Type 1 Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT07591766: Aerobic Dance Exercises in Fibromyalgia Syndrome

Sponsor: Istanbul University. Phase: NA. Conditions: Fibromyalgia (FM), Fibromyalgia Syndrome, Fibromyalgia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06445166: Propranolol for the Treatment of Kaposi Sarcoma in Adults

Sponsor: Washington University School of Medicine. Phase: PHASE2. Conditions: Kaposi Sarcoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06911866: A Phase Ib Study of RC1416 Injection

Sponsor: Nanjing RegeneCore Biotech Co., Ltd.. Phase: PHASE1. Conditions: Moderate to Severe Asthma

full page →ctgov ↗
›COMPLETEDphase readoutNCT02334956: Linking fMRI to Mobile Technologies in Addiction Research: Pathophysiology of Executive Deficits, Craving and Substance Use

Sponsor: University Hospital, Bordeaux. Phase: NA. Conditions: Addiction

full page →ctgov ↗
›TERMINATEDphase readoutNCT02797522: A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)

Sponsor: Arrowhead Pharmaceuticals. Phase: PHASE1. Conditions: Hepatitis B

full page →ctgov ↗
›COMPLETEDphase readoutNCT02437851: Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

Sponsor: AIDS Malignancy Consortium. Phase: PHASE2. Conditions: Anal Squamous Cell Carcinoma, HIV Infection, Stage 0 Anal Canal Cancer, Stage I Anal Canal Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06907251: Dapagliflozin for Long COVID Syndrome

Sponsor: Ottawa Heart Institute Research Corporation. Phase: PHASE3. Conditions: COVID - 19, Long COVID Syndrome, SARS CoV-2

full page →ctgov ↗
← prev
page 127 of 128
next →